Jonathan has almost 20 years of experience helping biopharmaceutical companies make better strategic decisions. His primary focus has been in the areas of pricing and market access and commercial strategy. Jonathan brings particularly deep expertise in understanding rapidly changing markets.
In his role as a Principal with ClearView Healthcare Partners, Jonathan helps clients navigate evolving and uncertain market environments. His areas of therapeutic focus include oncology and rare diseases. Jonathan also has recognized expertise in the digital medicine space. He recently spoke on commercial models for digital companies at the 2020 DTx West conference and at the European Pricing Forum. He has also lectured on valuation approaches and techniques at the Massachusetts Biotechnology Council, and has co-authored articles published in the Journal of Clinical Pathways, PharmaVOICE and In Vivo.
Before joining ClearView, Jonathan served as Managing Director and Head of Office for Eversana Management Consulting (fka Promidian Consulting). Jonathan began his career in life science at Vertex Pharmaceuticals, and has held leadership roles at Putnam Associates, IQVIA (fka The Amundsen Group), and L.E.K. Consulting.
Jonathan earned Bachelor of Arts degrees in economics and geology from Dartmouth College and an MBA from Harvard Business School.
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
David Gilman
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Steve Rubman
Debbi Amanti Belanger
Kim Goh
Slater Hurst
Dave Konciak
Charles Mathews
Mike Rizzo
Mike Roy
Ryan Tubman
Beko Binder
Jonny Betts
Dean Griffiths
Maneesh Gujrati
Austin Hubbert
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian